-
Mashup Score: 8Daniela Matei on Chemotherapy for Stage III Endometrial Cancer - 16 day(s) ago
An updated analysis of the randomized phase III trial found no survival benefit from the addition of pelvic radiation to chemotherapy in stage III endometrial cancer. Historically, such patients received radiotherapy to prevent pelvic recurrence, but in recent years systemic chemotherapy proved to be highly active.
Source: www.medpagetoday.comCategories: General Medicine NewsTweet
-
Mashup Score: 1
When market veterans gather, the talk often turns to memorable crashes. Last week should join the list.
Source: www.wsj.comCategories: General Medicine NewsTweet-
RT @ken_ragsdale: https://t.co/3oKldomRTy Will the Last Investor to Leave America Please Turn Out the Lights @DougCarel
-
-
Mashup Score: 9Does Chemoradiotherapy Boost Survival in Endometrial Cancer? - 3 month(s) ago
The addition of radiation to chemotherapy did not improve overall survival in patients with locally advanced endometrial cancer, a recent phase 3 trial found.
Source: www.medscape.comCategories: General Medicine News, Hem/OncsTweet-
Does #Chemoradiotherapy Boost Survival in #EndometrialCancer? The long-term results of @GOG 258 from Dr. @matei_dem on behalf of the @NRGonc Uterine Corpus Committee. Now online @JCO_ASCO. From @MedscapeObGyn. #gyncsm #ClinicalTrials https://t.co/iQIRag7YTB
-
-
Mashup Score: 3
Andrew Beal, the founder and owner of Beal Financial Corporation, tore down the Cox Mansion in Highland Park. He wants to build a new home on the site.
Source: www.dallasnews.comCategories: General Medicine News, Hem/OncsTweet-
RT @dallasnews: Billionaire who tore down Cox Mansion is a step closer to building new estate https://t.co/8UXWud4u1l
-
-
Mashup Score: 2Adjuvant Treatment for Endometrial Cancer - Expert Perspectives - 4 month(s) ago
expert roundtables by David Scott Miller, MD, FACOG, FACS; Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS; Pamela T. Soliman, MD, MPH Following surgery for intermediate- to high-risk endometrial cancer, clinicians and patients carefully weigh the risks and benefits of adjuvant therapies. Tumor characteristics used to guide treatment selection for advanced and recurrent endometrial cancer may eventually have a role in the selection of adjuvant therapy. “I tell patients that we could potentially reduce the
Source: expertperspectives.comCategories: General Medicine News, Hem/OncsTweet-
Adjuvant Treatment for Endometrial Cancer with Drs. Alex Olawaiye & @PamSolimanMD . From @eponcology. #gyncsm #endometrialcancer #adjuvant https://t.co/OrZsHeBNjL
-
-
Mashup Score: 0Faith-based cost-sharing seemed like an alternative to health insurance, until the childbirth bills arrived - 4 month(s) ago
Health care sharing ministries advertise reimbursements for members’ medical bills. But they are largely unregulated, and most have restrictions on maternity coverage.
Source: apple.newsCategories: General Medicine News, Hem/OncsTweet-
Uninsured while pregnant, she turned to a Christian cost-sharing group. Her family was left in debt. - NBC News https://t.co/jZ1pWfn1Fa
-
-
Mashup Score: 7
David S. Miller, MD, discusses the efficacy of selinexor in patients with advanced or recurrent TP53 wild-type endometrial cancer.
Source: www.onclive.comCategories: General Medicine News, Hem/OncsTweet-
Longer Follow-up of #Selinexor Maintenance for Patients with TP53wt Advanced or Recurrent Endometrial Cancer: From the Phase 3 ENGOT-EN5/ @GOG 3055/#SIENDO Study at #IGCS2024 #endometrialcancer #clinicaltrials #gyncsm @XPOVIOHCP https://t.co/aug2T0FMWP via @onclive
-
-
Mashup Score: 3581
MADISON, WI—In the hours following a violent rampage in Wisconsin in which a lone attacker killed at least two individuals and injured six others, citizens living in the only country where this kind of mass killing routinely occurs reportedly concluded Monday that there was no way to prevent the massacre from taking place. “This was […]
Source: theonion.comCategories: General Medicine News, Hem/OncsTweet-
RT @TheOnion: ‘No Way To Prevent This,’ Says Only Nation Where This Regularly Happens https://t.co/ccr3VmZzjD https://t.co/LIQ3Zat1mG
-
-
Mashup Score: 1Expert Roundtables Podcast: The Use of Biomarkers in the Management of Endometrial Cancer - Expert Perspectives - 5 month(s) ago
expert roundtables by David Scott Miller, MD, FACOG, FACS; Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS; Pamela T. Soliman, MD, MPH When combined with histological characteristics, molecular biomarkers support a personalized treatment approach for endometrial cancer. Selecting treatments based on a patient’s biomarkers may help to not only maximize treatment benefits but also prevent treatment-related toxicities in patients whose endometrial cancer is unlikely to respond to the therapies. Our featured
Source: expertperspectives.comCategories: General Medicine News, Hem/OncsTweet-
Expert Roundtables Podcast: The Use of #Biomarkers in the Management of #EndometrialCancer with @PamSolimanMD. From @eponcology . #gyncsm https://t.co/W3mLEmVSd6
-
-
Mashup Score: 0My Thoughts On The United Healthcare CEO Murder - 5 month(s) ago
UPDATE: Since recording this video, an arrest has been made (NOT JIMOTHY) and BCBS completely rescinded their proposed anesthesia policy!Also, I hinted at wa…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet-
Thoughts On The United Healthcare CEO Murder https://t.co/eJ4kZIkjTV via @YouTube
-
Daniela Matei on Chemotherapy for Stage III Endometrial Cancer. The long-term results of @GOG 258 from Dr. @matei_dem on behalf of the @NRGonc Uterine Corpus Committee. Now in print in @JCO_ASCO. From @medpagetoday. https://t.co/K42wxY1fqG